CDTX icon

Cidara Therapeutics
CDTX

Overview Fund Activity

48 hedge funds and large institutions have $102M invested in Cidara Therapeutics in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
+6
Holders Change %
+14.29%
% of All Funds
1.09%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
10
Increased
16
Reduced
9
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BB
BB Biotech
Switzerland
+$6.53M
2
GPP
Great Point Partners
Connecticut
+$5.44M
3
PVI
Pura Vida Investments
New York
+$1.87M
4
ACM
Alethea Capital Management
Washington
+$355K
5
Renaissance Technologies
Renaissance Technologies
New York
+$253K

Top Sellers

1
Deutsche Bank
Deutsche Bank
Germany
-$672K
2
EAM
Eventide Asset Management
Massachusetts
-$626K
3
SM
Sabby Management
Florida
-$521K
4
ARTA
A.R.T. Advisors
New York
-$231K
5
Squarepoint
Squarepoint
New York
-$167K
Name Holding Trade Value Shares
Change 		Shares
Change %
ARTA
51
A.R.T. Advisors
New York
– -$231K -1,430 Closed
Squarepoint
52
Squarepoint
New York
– -$167K -1,030 Closed
NFA
53
Nationwide Fund Advisors
Ohio
– -$66K -410 Closed
1 2
3